Pharmacy to Dose: The Critical Care Podcast

Nick Peters

  • 1 hour 26 minutes
    RSI: Part II

    Rapid Sequence Intubation (RSI): Part II

    Special Guest: Christine Groth, PharmD, FCCM, BCCCP @GrothChristine

    Angela Slampak-Cindric, PharmD, BCPS, BCCCP, FCCM @AngelaSlampak

    Kevin Kaucher, PharmD, BCCCP

     

    04:05 – Guideline development/involvement

    12:50 – 2024 guideline overview

    25:10 – Pharmacotherapy recommendations/considerations

    42:40 – Non-pharmacologic recommendations/guideline insights

    70:30 – Research ideas/conclusions

     

    Reference List: https://pharmacytodose.files.wordpress.com/2024/05/rsi-part-ii-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    3 May 2024, 2:46 am
  • 53 minutes 46 seconds
    Trial of the Week: ESETT

    Trial of the Week: ESETT

    Special Guest: Ashley McCormick, PharmD, BCPS, BCCCP

     

    Ashley McCormick joins to discuss the April Trial of the Week “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus” the ESETT study, published in NEJM in 2019.

    We set the scene by reviewing ASM PK/PD properties and discussing if there was a standard of care first-line treatment. Then we do a deep dive into the ESETT trial of the week. Did the 75kg dose cap influence results? How appropriate was the BZD dosing? How does this % of seizure cessation compare to other studies? Where did this dosing scheme come from? Trial fun facts, medication safety considerations, and much, much more.

    Reference list: https://pharmacytodose.files.wordpress.com/2024/04/esett-trial-of-the-week-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    30 April 2024, 8:41 pm
  • 1 hour 10 minutes
    Thrombolytic Dosing in PE: Versus Series

    Thrombolytic Dosing in PE: Versus Series

    Special Guest: Lauren Igneri, PharmD, BCPS, BCCCP, FCCM

     

    05:20 – High-risk PE

    23:00 – Intermediate-risk

    37:10 – Cardiac arrest

    52:30 – Closing arguments

    57:15 – Bonus: TNK v. tPA

     

    Reference List: https://pharmacytodose.files.wordpress.com/2024/04/thrombolytic-dosing-in-pe-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    25 April 2024, 11:10 am
  • 40 minutes 11 seconds
    Trial of the Week: SEPSISPAM

    Trial of the Week: SEPSISPAM

    Special Guest: Katherine Spezzano, PharmD, MBA, BCCCP @KatSpazPharmD

     

    Katherine Spezzano joins to discuss the April Trial of the Week “High versus Low Blood-Pressure Target in Patients with Septic Shock” the SEPSISPAM study, published in NEJM in 2014.

    We set the scene by reviewing the concept of autoregulation, guideline recommendations, and pre-SEPSISPAM research assessing BP goals in sepsis. Then we do a deep dive into the SEPSISPAM trial of the week. Would we see these same results with other vasopressors? Did each group meet their BP goal range? How do we balance AKI prevention and longer ICU LOS? What do our guidelines recommend now? Trial fun facts, alternate trial acronym ideas, and much more!

     

    Reference list: https://pharmacytodose.files.wordpress.com/2024/04/sepsispam-trial-of-the-week-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    23 April 2024, 4:11 pm
  • 1 hour 25 minutes
    Glycemic Control in the Critically Ill: Part II

    Glycemic Control in the Critically Ill: Part II

    Special Guests: Judi Jacobi, PharmD, FCCP, MCCM, BCCCP @JudiJacobi

    Michael Sirimaturos, PharmD, BCNSP, BCCCP, FCCM @MSirimaturos

     

    04:10 – Becoming panel members

    11:50 – Guideline scope and PICO questions

    21:35 – 2012 v. 2024 guidelines

    28:05 – Effect of TGC-FAST

    30:40 – 2024 guideline deep-dive

    42:00 – Clinical decision support tools

    50:00 – Pediatric recommendations

    54:40 – Important future research topics

    66:05 – Guideline manuscript writing

    76:10 – Take-home points

     

    Reference List: https://pharmacytodose.files.wordpress.com/2024/04/glycemic-control-in-the-icu-part-ii-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    19 April 2024, 4:21 am
  • 1 hour 20 minutes
    November 2023 Literature Review Series

    Literature Review Series

    November 2023

    Special Guests: Arjay Mendoza, PharmD, BCPS, AAHIVP

    Brock Townsend, PharmD @Townsend_PharmD

     

    04:30 – Featured Articles

    35:25 – Cardiology

    48:05 – Precision-based medicine potpourri

    58:50 – Infectious Diseases

    69:10 – PharmD

     

    Reference List: https://pharmacytodose.files.wordpress.com/2024/04/november-lrs-2023-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    17 April 2024, 5:52 am
  • 59 minutes 32 seconds
    Trial of the Week: SOAP II

    Trial of the Week: SOAP II

    Special Guest: Jessica Casey, PharmD, BCPS, BCCP @jmc_cardspharmd

     

    Jessica Casey joins to discuss the April Trial of the Week “Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” the SOAP II study, published in NEJM in 2010.

    We set the scene by reviewing catecholamine vasopressor receptor physiology, guideline recommendations, and pre-SOAP II research. Then we do a deep dive into the SOAP II trial of the week. Did including all forms of shock help or hurt? How does the mortality in this study compare with others? Would this have been as positive of a study in 2024? What do the guidelines recommend now? Is dopamine dead? Will anyone take norepinephrine’s throne? Jessica and I review trial fun facts, stand-out supplementary materials, and much, much more.

     

    Reference list: https://pharmacytodose.files.wordpress.com/2024/04/soap-ii-trial-of-the-week-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    9 April 2024, 4:33 pm
  • 46 minutes 55 seconds
    Trials of the Week: Nimodipine Landmark Studies

    Trials of the Week: Landmark Nimodipine Studies

    Special Guest: Salia Farrokh, PharmD, BCCCP, FNCS @salia_farrokh

     

    Salia Farrokh joins to highlight two landmark studies with nimodipine, “Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage” published in NEJM in 1983 and “Effect of Oral Nimodipine on Cerebral Infarction and Outcome after Subarachnoid Hemorrhage: British Aneurysm Nimodipine Trial” published in 1989 in BMJ.

    We review aSAH treatments in the 1970’s and 1980’s and what evidence existed for nimodipine use before highlighting our two trials of the week. How does the study methodology compare from then to now? Where did our nimodipine dosing regimen come from? Is the term cerebral artery vasospasm out of date? Is it still appropriate to use evidence from the 1980’s in the 2020’s? Is there more to research with respect to nimodipine? What to do with missed nimodipine doses? We do a deep dive into all things nimodipine for aSAH, discussing the above and much more.

     

    Reference list:  https://pharmacytodose.files.wordpress.com/2024/04/nimodipine-trial-of-the-week-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    5 April 2024, 5:46 pm
  • 1 hour 24 minutes
    Norepinephrine Position Paper and Sepsis Research Priorities

    Norepinephrine Position Paper and Sepsis Research Priorities

    Special Guests: Brittany Bissell Turpin, PharmD, PhD, FCCM, BCCCP @BissellBrittany

    Patrick Wieruszewski, PharmD, BCCCP @pwierusz

    Seth Bauer, PharmD, FCCM, FCCP, BCCCP @SethRBauer

     

    07:30 – Norepinephrine position paper introduction

    11:35 – When did we realize this and what are the implications?

    36:00 – Key task force take-aways

    51:00 – SSC Research Committee history

    56:00 – Submitting and ranking research questions

    27:00 – Top 5 clinical sepsis research priorities

    62:00 – Basic science priorities

     

    Reference List: https://pharmacytodose.files.wordpress.com/2024/04/norepi-position-paper-and-sepsis-research-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    3 April 2024, 4:27 am
  • 1 hour 5 minutes
    Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket

    Final Four Preview and More: 2024 Critical Care Trials March Madness Bracket

     

    Sepsis/Fluids Bracketologist: Clay Small, PharmD, BCCCP

    CV/Pulm Bracketologist: Jolie Gallagher, PharmD, BCCCP

    Bleeding/BG Bracketologist: Jason Hecht, PharmD, BCPS, BCCCP, FCCM

    Neuro/PADIS Bracketologist: Karen Berger, PharmD, FASHP, FCCM, BCPS, BCCCP

     

    06:10 – Region recaps

    32:10 – Final Four preview and predictions

    45:30 – Revisiting pre-tournament predictions

     

    PubMed links for all 68 Critical Care March Madness trials: https://pharmacytodose.files.wordpress.com/2024/03/critical-care-trials-reference-list-all-regions.pdf

     

    Listener Bracket: https://pharmacytodose.com/2024/04/01/final-four-2024-critical-care-trials-march-madness-bracket-preview-and-recap/

     

    2024 Critical Care Trials March Madness blank bracket: https://pharmacytodose.com/2024/03/17/2024-critical-care-trials-march-madness-bracket/

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    1 April 2024, 11:59 pm
  • 1 hour 16 minutes
    October 2023 Literature Review Series

    Literature Review Series

    October 2023

    Special Guests: Hailey Burns, PharmD @Hailey_rx36

    Caitlyn Simonson, PharmD

     

    03:45 – Featured Articles

    38:15 – Neuro

    50:10 – EM/Tox/Trauma

    61:50 – Renal/Endocrine

    66:38 – PharmD

    70:10 – Sweet Emotion

     

    Reference List: https://pharmacytodose.files.wordpress.com/2024/03/october-lrs-2023-references.pdf

     

    PharmacyToDose.Com

    @PharmacyToDose

    [email protected]

    Learn more about your ad choices. Visit megaphone.fm/adchoices

    29 March 2024, 4:55 am
  • More Episodes? Get the App
© MoonFM 2024. All rights reserved.